Carriers of a genetic mutation show increased dependence on tobacco

December 20, 2013

Scientists at the Institut Pasteur, the French National Center for Scientific Research (CNRS) and Pierre and Marie Curie University (UPMC) have recently proven that, in mice, nicotine intake– nicotine is the main addictive substance in tobacco – is heavily regulated by a genetic mutation that is very common in humans. This mutation affects the neuronal nicotinic receptor, disrupting its function and resulting in partial inactivation of the "reward circuit". Carriers of this mutation therefore have to increase their consumption to feel the effects of tobacco. These results, published online on December 3, 2013 in Molecular Psychiatry, pave the way for the development of new smoking cessation treatments that target carriers of this mutation.

During , binds to , thus activating the "reward circuit", a neuronal system responsible for a number of responses – including a feeling of well-being – during normal function. The effect of nicotine on the brain compensates for withdrawal symptoms felt by smokers when they are deprived of tobacco. As a result, a person's tobacco consumption is closely linked to the sensitivity of these nicotinic receptors.

The teams led by Uwe Maskos, who heads the Integrative Neurobiology of Cholinergic Systems Unit at the Institut Pasteur / CNRS, and by CNRS scientist Philippe Faure, who manages the Neurobiology of Adaptive Processes laboratory (CNRS / UPMC), have recently made a discovery proving that nicotine addiction may be influenced by an individual's genetic heritage. These scientists show that, in mice, a genetic mutation resulted in a marked reduction in sensitivity to nicotine. Carriers of this gene therefore require a higher dose of tobacco than non-carriers in order to obtain the same amount of pleasure - somewhere on the order of three times more.

The mutation characterized by the scientists affects part of the nicotinic receptor. The presence of this mutation disrupts the normal function of the nicotinic receptor, partially inactivating the "reward circuit".

This mutation occurs frequently in humans. Other studies suggest that it is present in 35% of Europeans, and in nearly 90% of heavy smokers. These discoveries pave the way for the development of "personalized" smoking cessation treatments for individuals who carry this genetic mutation.

Explore further: Eliminating protein in specific brain cells blocks nicotine reward

More information: Nicotine consumption is regulated by a human polymorphism in dopamine neurons, Molecular Psychiatry, December 3, 2013.

Related Stories

Internet addiction—Causes at the molecular level

August 29, 2012

Everybody is talking about Internet addiction. Medically, this phenomenon has not yet been as clearly described as nicotine or alcohol dependency. But a study conducted by researchers from the University of Bonn and the Central ...

Recommended for you

Where belief in free will is linked to happiness

January 23, 2017

Western and Asian cultures tend to have different core beliefs around free will. In a recent study published in Frontiers in Psychology, Jingguang Li, professor at Dali University, and his research team show the link between ...

Study reveals areas of the brain impacted by PTSD

January 23, 2017

Researchers at Boston University School of Medicine (BUSM) and the VA Boston Healthcare System are one step closer to understanding the specific nature of brain changes associated with Posttraumatic Stress Disorder (PTSD).

For health and happiness, share good news

January 22, 2017

Service members, including both active and recently separated, have been called upon to fight overseas and to assist during natural disasters at home. They can face unique challenges when they return in both the workplace ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.